Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Six German patients test wireless artificial retina

This article was originally published in Clinica

Executive Summary

After 12 years of research and E17.5m ($26.8m) funding, Germany's artificial retina programme came of age this month when devices developed by local researchers were implanted in six long-term blind individuals. The EPIRET3 artificial implants, developed by Professor Wilfried Mokwa and a team from RWTH Aachen/the Duisburg Fraunhofer institute, are claimed to be the world's first such wireless implants.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046502

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel